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Abstract
CD28 is the major costimulatory receptor required for activation of naı ¨ve T cells, yet CD28 costimulation affects the
expression level of surprisingly few genes over those altered by TCR stimulation alone. Alternate splicing of genes adds
diversity to the proteome and contributes to tissue-specific regulation of genes. Here we demonstrate that CD28
costimulation leads to major changes in alternative splicing during activation of naı ¨ve T cells, beyond the effects of TCR
alone. CD28 costimulation affected many more genes through modulation of alternate splicing than by modulation of
transcription. Different families of biological processes are over-represented among genes alternatively spliced in response
to CD28 costimulation compared to those genes whose transcription is altered, suggesting that alternative splicing
regulates distinct biological effects. Moreover, genes dependent upon hnRNPLL, a global regulator of splicing in activated T
cells, were enriched in T cells activated through TCR plus CD28 as compared to TCR alone. We show that hnRNPLL
expression is dependent on CD28 signaling, providing a mechanism by which CD28 can regulate splicing in T cells and
insight into how hnRNPLL can influence signal-induced alternative splicing in T cells. The effects of CD28 on alternative
splicing provide a newly appreciated means by which CD28 can regulate T cell responses.
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Introduction
Effective activation of naı ¨ve T cells requires both T cell receptor
(TCR) stimulation and CD28 costimulation. Signals through
CD28 promote expression of growth and survival factors, and
glucose metabolism, enabling T cell expansion and differentiation.
Although CD28 is the major costimulatory receptor for activation
of naı ¨ve T cells, previous studies have found few CD28-specific
changes in gene transcription upon TCR and CD28 co-
engagement [1,2]. Thus, CD28 costimulation is thought to mainly
amplify TCR signals rather than have specific effects on the cell
state. Recent studies have revealed that alternative splicing (AS), as
well as gene-level transcription, play important regulatory roles in
T cell biology [3]. AS can increase proteome diversity by
increasing the number of distinct mRNA transcripts from a single
gene locus. Transcript variation can modify protein interaction
networks by removing or inserting protein domains, altering
subcellular localization, or regulating gene expression in different
cell types and cell states. AS can regulate gene expression by
eliminating binding sites for translational repression by micro-
RNAs and by targeting mRNAs for nonsense-mediated decay [4].
Although the biologic effects of AS are only beginning to be
appreciated, recent studies have revealed roles for AS in regulating
stem cell pluripotency and differentiation, as well as neuronal
differentiation, diversity and plasticity [5]. AS also regulates genes
important for immune cell differentiation and function [6]. These
findings led us to hypothesize that CD28 may exert some of its
regulatory effects through AS.
To test this hypothesis, we compared genome-wide AS in naı ¨ve
T cells following stimulation through TCR alone or TCR plus
CD28 costimulaton. For our genomic analyses, we used rigorously
naı ¨ve T cells to circumvent issues that have complicated the
interpretation of previous studies, which used human peripheral
blood T cells or T cell lines to identify genes responsive to the
activation of naı ¨ve T cells. Studies with human peripheral T cells
have been confounded by the unintentional admixture of
previously activated or memory T cells [1,2,7], which differ from
naı ¨ve T cells in their requirements for activation [8]. In addition,
studies of human T cells stimulated with PMA or PHA cannot
distinguish the effects of TCR versus CD28 signaling [7].
Microarray studies using T cell lines, such as Jurkat cells, may
be difficult to extend to primary cells because of aberrant signaling
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e40032in Jurkat cells [9,10]. Therefore, use of rigorously naı ¨ve T cells
enabled analyses of specific effects of TCR and CD28 during
initial T cell activation.
Using exon microarrays, we identified CD28-specific changes in
transcription and AS across diverse gene families. Remarkably,
CD28 costimulation affected many more genes through alternative
splicing than by altering transcription level. While the expression
levels of only 140 transcripts were significantly altered in a CD28-
specific fashion, the splicing of 1,047 transcripts was altered by
TCR plus CD28 activation as compared to TCR activation alone.
The marked influence of CD28 costimulation on splicing in T cells
led us to investigate whether CD28 signaling promotes expression
of factors that regulate splicing. We focused on the global splicing
regulatory factor hnRNPLL because recent work has identified
hnRNPLL as a regulator of splicing in activated T cells. We
determined that the expression of hnRNPLL is CD28 dependent,
providing a mechanism by which CD28 can control splicing in T
cells and new insight into the function of hnRNPLL as a mediator
of signal-induced alternative splicing in T cells [11].
Results
Transcripts Affected by TCR and TCR/CD28 Activation
To model T cell activation, we cultured rigorously naı ¨ve CD4 T
cellswithbeadscoatedwithanti-CD3pluseitheranti-CD28(TCR/
CD28) or a control Ig (TCR) for 24 hours. We then isolated and
reverse-transcribedRNA,andhybridizedtheresultingDNAtoexon
microarrays. Analysis of transcript abundance showed that 8,966 of
the17,689transcriptsassessedweredesignatedas‘‘present’’(i.e.,the
transcripts were expressed at a detectable level above background).
Most(7,311)ofthesetranscriptsweresharedamongthenaı ¨ve,TCR-
activated, and TCR/CD28-activated T cells (Figure 1A). A few
unique transcripts were identified that were not seen in the other
states: 409 in naı ¨ve T cells, 40 in TCR-activated T cells, and 255 in
TCR/CD28-activated T cells. The unique transcripts for each
condition (naive, TCR-activated, and TCR/CD28-activated) are
listed in Table S1. We used the Gene Ontology framework to
categorize the biological processes for these unique transcripts and
determine whether some biological functions might be over-
represented in upregulated transcripts. We found that these unique
transcriptswereenrichedforprocessesassociatedwithcellcycleand
chemotaxis in the TCR/CD28-activated group. All statistically
enrichedbiologicalprocessesfortheseuniquetranscriptsarelistedin
Table S2.
Wenextanalyzedchangesingenetranscriptionlevel,usingacutoff
of 2-fold differences and measuring significance using empirical
Bayesian testing [12]. 1,481 genes showed a greater than 2-fold
change in expression level in T cells activated with anti-CD3 alone
comparedtonaı ¨vecells,and3,806genesshowedtranscription-level
differences in T cells activated by anti-CD3 plus anti-CD28
compared to naı ¨vecells. Wefound only 140 genes withgreater than
2-fold transcriptionaldifferences inTcellsactivated throughTCR/
CD28 as compared to T cells activated through TCR alone, a
relatively small number of genes, but consistent with previous work
[1,2]. The transcripts with the largest fold changes (up- and down-
regulation) are shown with independent replicates (Figure S1).
Volcano plots summarize both fold-change and t-test criteria and
highlight some of the transcripts with significant differences in
expression (Figure S2). All transcripts with expression-level changes
greater than 2-fold are provided in Table S3. As expected, these
differences included characteristic changes of naı ¨ve to effector
differentiationincludingup-regulationofTbet(Tbx21),CD25(Il2ra),
and down-regulation of IL-7Ralpha chain(CD127, Il7r).
We then investigated changes in splicing, and measured
significance using two statistical tests for splicing (MADS and
MIDAS) [13]. We considered only differences in splicing that
had statistically significant p values in both statistical tests. Using
this criterion, we found 1,319 genes with alterations in splicing
when T cells were activated through TCR alone compared to
naı ¨ve T cells, and 1,575 transcripts with alterations in splicing
when naı ¨ve T cells were activated through TCR/CD28
compared to naı ¨ve T cells. In contrast to its effects on gene-
level transcription of only 140 genes, TCR/CD28 activation
altered the splicing of 1,047 transcripts, as compared to T cells
activated through TCR alone (Figure 1B). The unique
transcripts showing AS in each condition are detailed in Table
S4. Thus, activation of naı ¨ve T cells by TCR plus CD28 exerts
effects on nearly 8 times as many genes by modulating splicing
than by modulating transcription, when compared to TCR
activation alone.
Figure 1. Genes are both differentially expressed and alter-
nately spliced following TCR and CD28 activation. (A) Venn
diagram showing the number of transcripts expressed in naı ¨ve, TCR-
activated, and TCR/CD28-activated T cells. The unique transcripts for
each group are provided in Table S1. These unique transcripts are
enriched for Gene Ontology biological processes, provided in Table S2.
(B) Venn diagram showing the number of transcripts differentially
spliced in naı ¨ve, TCR-activated, and TCR/CD28-activated T cells. The
unique transcripts (non-overlapping parts of the Venn diagram) are
listed in Table S4.
doi:10.1371/journal.pone.0040032.g001
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Transcriptional Regulation versus Alternate Splicing in
Response to CD28 Costimulation
Regulation of distinct biological processes can be detected by
the coordinate regulation of sets of genes related to each process.
We asked whether the genes altered by AS or by transcriptional
level were the same or different. We compared the Gene Ontology
annotations for genes with altered transcription levels under
conditions of TCR versus TCR/CD28 activation (as compared to
naı ¨ve cells), or alternately spliced genes under conditions of TCR
versus TCR/CD28 activation (as compared to naı ¨ve cells)
(Figure 2). We found 632 biological processes of the Gene
Ontology framework represented by the genes altered by splicing,
transcription, and activation method (TCR or TCR/CD28). We
categorized these biological processes into the following four
groups of genes (each compared to naive T cells): those altered in
splicing with TCR activation, altered in splicing with TCR/CD28
activation, altered in transcription level with TCR activation, and
altered in transcription level with TCR/CD28 activation
(Figure 2).
Of the 632 biological processes seen across these conditions,
some were seen in a subset of conditions, and some were uniquely
seen in only one condition; 187 biological processes were unique to
transcription, 230 were unique to AS, and 215 were shared
between AS and transcription. For example, the biological process
called ‘‘regulation of protein amino acid phosphorylation’’ was
seen in all four conditions. The biological processes that were
unique to each of the four conditions (boxed in green in Figure 2)
are listed in Tables S5 and S6. Unique biological processes related
to RNA processing were seen among the genes altered by
transcription in TCR/CD28-activated cells as compared to naive
cells, and unique biological processes related to RNA splicing were
seen among the genes altered by splicing in TCR/CD28-activated
cells as compared to naive cells (Table S5). We also examined the
biological processes for all the genes that were differentially
expressed and those alternately spliced when comparing TCR and
TCR/CD28 activation (Table S6). Some of the functionally-
related families of genes that are extensively affected by CD28-
induced alternative splicing (e.g. regulation of purine metabolism,
regulators of mitotic cell cycle) are consistent with the known
biological effects of CD28 on T cell expansion. However, other
families are novel (e.g., RNA processing, RNA splicing, DNA
metabolic process). Thus, we again found enrichment of biological
processes related to RNA processing and RNA splicing in the
genes differentially spliced between TCR-activated T cells and
TCR/CD28-activated T cells. Analysis of these functionally-
related families of genes showed that they are densely intercon-
nected based on prior co-expression, physical interaction and co-
localization data (Figure S3). Thus the function of these genes may
be co-ordinately regulated not only at the level of transcript
abundance, but also by alternative splicing. It is interesting, but
not immediately apparent why biological processes related to
splicing should be the function of some of the genes themselves
altered by splicing upon T cell activation. Thus, our studies
indicate that CD28 costimulation can influence specific biological
processes through alterations of transcription expression level or
AS.
Transcriptional Changes Mediated by CD28
Costimulation
To validate transcriptional changes identified by the exon
microarrays, we compared the mRNA and protein expression of
several genes greatly altered in a CD28-specific fashion. (i.e.,
genes greatly affected by TCR stimulation plus CD28 costim-
ulation as compared to TCR stimulation alone). CD226, a
costimulatory receptor in the CD226/TIGIT pathway, and the
cytokine IL-3 were among the genes whose transcription were
most upregulated in a CD28-specific fashion. Transcript levels
of the CD226 and IL-3 genes were increased by ,6 fold upon
treatment of naı ¨ve T cells with anti-CD3 plus anti-CD28 as
compared with CD3 alone (Table S3). To investigate the extent
to which CD226 and IL-3 protein expression are CD28-
dependent, we analyzed expression of CD226 protein by flow
cytometry and production of IL-3 by cytokine bead array
following activation of naive CD4 T cells over a 72 hour period
(Figure 3). When naı ¨ve CD4 T cells were stimulated only with
anti-CD3, there was negligible expression of CD226 at 24, 48
or 72 hr. In contrast, CD4 T cells stimulated with anti-CD3
plus anti-CD28 showed increased expression of CD226 at
24 hrs, and CD226 expression was sustained at even higher
levels at 48 and 72 hours (Figures 3A and 3B). Thus, induction
Figure 2. Functional families for genes whose transcription or
splicing is affected by TCR alone or TCR/CD28. Biological
processes, as defined by Gene Ontology, were counted if at least 10
genes comprising that process were present and were clustered in four
groups: transcription or splicing in T cells activated through TCR alone
or through TCR and CD28. The biological processes that were unique to
each of the four conditions are indicated by the green boxes, and are
listed in Tables S5 and S6. If biological processes were statistically
enriched compared to the whole genome, color indicates adjusted p
values of enrichment ,0.05 (shades of red), p.0.05 (grey).
doi:10.1371/journal.pone.0040032.g002
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of CD28. Similarly, the production of IL-3 was CD28
dependent. IL-3 was produced only when naı ¨ve CD4 T cells
were stimulated with anti-CD3 plus CD28 (Figure 3C). When
naı ¨ve CD4 T cells were stimulated with anti-CD3 alone, IL-3
production was negligible (below the detection limit of our
assay). The same results were seen using naive OT-II
+/+
TCRa
2/2 T cells or naı ¨ve CD4 T cells from C57BL/6 mice.
The chemokine receptor CCR9, was identified as a gene whose
transcription was downregulated in a CD28-specific fashion. To
validate this, we analyzed CCR9 protein expression by flow
cytometry following activation of naı ¨ve CD4 T cells over a period
of 72 hours. Naı ¨ve CD4 T cells expressed CCR9 protein.
Stimulation of naı ¨ve CD4 T cells with anti-CD3 reduced
expression of CCR9 protein by ,50%. When naı ¨ve CD4 T cells
were stimulated with anti-CD3 plus anti-CD28, CCR9 expression
was no longer detected (Figure 4). The greater effects of anti-CD3
plus anti-CD28 stimulation as compared to anti-CD3 alone on
CCR9 cell surface expression are consistent with the transcription
data (CCR9 mRNA levels decreased ,9 fold with anti-CD3, and
36-fold with anti-CD3 plus ant-CD28). Taken together, our
studies of CD226, IL-3 and CCR9 protein expression validate our
exon microarray data. These analyses demonstrate that CD226,
IL-3 and CCR9 protein expression are among the relatively small
number of genes regulated in a CD28-specific fashion. Together,
these results also validate that the exon microarray can successfully
identify changes in gene expression.
CD28 Stimulation Regulates Expression of the Splicing
Factor hnRNPLL
The dramatic effects of CD28 costimulation on AS led us to
hypothesize that CD28 costimulation might regulate global
splicing factors in T cells. Because recent data have shown the
splicing factor hnRNPLL to be critical for alternative splicing
following T cell activation and identified a set of genes that require
hnRNPLL to undergo alternative splicing [14], we investigated
whether hnRNPLL was involved in CD28-dependent AS using
two complementary approaches. First, we reasoned that if
hnRNPLL were involved in specifying the set of genes that
underwent alternative splicing with TCR/CD28 stimulation
versus TCR stimulation alone, then genes that are known to
depend on hnRNPLL for splicing should be enriched among those
alternatively spliced in the TCR/CD28 condition. We, therefore,
used the set of 33 functionally validated hnRNPLL ‘‘splicing
targets’’ from Oberdoerffer et al. (Table 1) as a query set of genes
to ask whether hnRNPLL might dictate part of the alternative
splicing seen in TCR/CD28 versus TCR conditions. We
calculated the overlap of these validated hnRNPLL target genes
with the genes displaying significant alternative splicing in CD3/
CD28 versus CD3 conditions. Statistical significance of the
overlap was calculated using the hypergeometric distribution.
We found that the 5 of 33 hnRNPLL target genes were
alternatively spliced following TCR/CD28 stimulation compared
to CD3 stimulation alone, a number higher than expected by
chance alone (p=0.004) (Figure 5). This result suggested that the
difference in alternative splicing in the presence of CD28
costimulation may be due, in part, to the effects of hnRNPLL.
We next examined whether CD28 regulated hnRNPLL
expression. We compared hnRNPLL mRNA and protein
expression in naı ¨ve T cells stimulated with anti-CD3 alone or
anti-CD3 plus anti-CD28. For analyses of hnRNPLL mRNA, we
cultured sorted naı ¨ve CD4 T cells with anti-CD3 alone or anti-
CD3 plus anti-CD28 and analyzed hnRNPLL mRNA levels at 5,
12 and 24 hours by qPCR. We found that hnRNPLL mRNA
expression is increased in a CD28-specific fashion (Figure 6). The
levels of hnRNPLL mRNA remained comparably low in
unstimulated CD4 T cells and T cells cultured with anti-CD3
alone. In contrast, hnRNPLL mRNA levels were significantly
increased by TCR/CD28 stimulation at 12 hr after stimulation
and increased further by 24 hr after stimulation (2 fold and 5 fold,
respectively).
To analyze expression of hnRNPLL protein, we cultured
sorted naı ¨ve CD4 T cells with anti-CD3 or anti-CD3 plus anti-
CD28, and analyzed hnRNPLL protein expression 24, 48 and
72 hours later by Western blotting. The expression of
hnRNPLL protein was negligible in unstimulated T cells and
was only detected in T cells stimulated with anti-CD3 alone
after 72 hr of stimulation (Figure 7). In contrast, in T cells
stimulated with anti-CD3 plus anti-CD28, hnRNPLL protein
was induced by 24 hours, increased to higher levels by 48 hours
and sustained at 72 hr. Thus, CD28 costimulation is a critical
inducer of hnRNPLL expression, and hnRNPLL splicing targets
are enriched in those genes undergoing AS following CD28
costimulation. These findings suggest that one mechanism by
which CD28 may exert its effects on splicing could be through
promoting and sustaining expression of hnRNPLL.
Discussion
CD28 is the major costimulatory receptor involved in activation
of naı ¨ve T cells, but the molecular processes activated by CD28
and how these integrate with TCR are still not well understood.
Figure 3. CD28 signaling increases CD226 expression and IL-3
secretion in CD4 T cells. Sorted naı ¨ve CD4+CD25- T cells from C57BL/
6 wild type mice were stimulated with bead-bound anti-CD3 alone (A)
or anti-CD3 plus anti-CD28 (B) for the indicated times. Cells were
stained for CD226 surface expression (A, B) and supernatants were used
to quantify IL-3 secretion (C). Data were acquired by flow cytometry and
analyzed using FlowJo software. Asterisk (*) indicates below detection
limit (1.1 pg/mL). These results are representative of at least 3
independent experiments.
doi:10.1371/journal.pone.0040032.g003
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PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e40032Figure 4. CD28 signaling downregulates CCR9 surface expression on CD4 T cells. Sorted naı ¨ve CD4+CD25- T cells from wild type C57BL/6
mice were stimulated with bead-bound anti-CD3 alone or anti-CD3 plus anti-CD28 for 72 h. CCR9 surface expression was examined by flow
cytometry. These results are representative of at least 3 independent experiments.
doi:10.1371/journal.pone.0040032.g004
Table 1. Mouse orthologs of genes depending on hnRNPLL for alternative splicing [14].
Gene Symbol Gene Name
Ptprc protein tyrosine phosphatase, receptor type, C
Wac WW domain containing adaptor with coiled-coil
Cd44 CD44 antigen
Rad54b RAD54 homolog B (S. cerevisiae)
Stat5a signal transducer and activator of transcription 5A
Scd2 stearoyl-Coenzyme A desaturase 2
Snrpa1 small nuclear ribonucleoprotein polypeptide A’
Cflar CASP8 and FADD-like apoptosis regulator
Txndc5 thioredoxin domain containing 5
Fasn fatty acid synthase
Parg poly (ADP-ribose) glycohydrolase
Eif3d eukaryotic translation initiation factor 3, subunit D
Pxdn peroxidasin homolog (Drosophila)
Eif4g3 eukaryotic translation initiation factor 4 gamma, 3
Hspa14 heat shock protein 14
Gstm2 glutathione S-transferase, mu 2
Dusp2 dual specificity phosphatase 2
Traf 1 TNF receptor-associated factor 1
Ywhaz tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
Chordc1 cysteine and histidine-rich domain (CHORD)-containing, zinc-binding protein 1
Rbm14 RNA binding motif protein 14
Tuba1b tubulin, alpha 1B
Sirt5 sirtuin 5 (silent mating type information regulation 2 homolog) 5 (S. cerevisiae)
Tcfe3 transcription factor E3
Nap 1l1 nucleosome assembly protein 1-like 1
Alg11 asparagine-linked glycosylation 11 homolog (yeast, alpha-1,2-mannosyltransferase)
Ppan peter pan homolog (Drosophila)
Myst4 MYST histone acetyltransferase monocytic leukemia 4
Cd96 CD96 antigen
Runx3 runt related transcription factor 3
Usp20 ubiquitin specific peptidase 20
Myg1 melanocyte proliferating gene 1
Tnfsf8 tumor necrosis factor (ligand) superfamily, member 8
Emboldened lines indicate overlap with genes significantly alternatively spliced in CD3/CD28 vs. CD3 comparison.
doi:10.1371/journal.pone.0040032.t001
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immunoregulatory effects. We show that signals through CD28
lead to profound changes in splicing in naı ¨ve T cells upon their
activation. CD28 costimulation induces specific effects on splicing
in T cells, beyond the effects of TCR stimulation alone. CD28
costimulation affects nearly 8 times as many genes through
regulation of alternate splicing than by regulation of gene
transcription. While it is well established that CD28 can increase
gene transcription and mRNA stability, there are relatively few
CD28-specific changes in gene transcription upon TCR and
CD28 co-engagement. The effects of CD28 on alternate splicing
provide a previously unappreciated means by which CD28 can
regulate T cell responses.
Our findings emphasize that examination of transcript abun-
dance alone provides only a partial picture of signal-driven gene
regulation, and that AS may have broad effects on T cell function.
Studies of alternate splicing have demonstrated that .70% of
genes are alternately spliced [3], but analyses of signal-induced
splicing in T cells thus far have focused on only a handful of genes
(e.g., CD45, CD44) [6]. Recent work from genome-wide
association studies also has pointed to the significance of
alternative splicing in immune-mediated diseases. For example,
splice variants of the T cell inhibitory receptor CTLA-4 are
associated with susceptibility to type 1 diabetes and autoimmune
thyroid disease [15,16,17]. Our results give impetus to further
studies of splice variants important for T cell biology.
Recent studies have identified hnRNPLL to be an important
regulator of splicing in the nervous system and the immune system.
The immune system and the nervous system both have the
capacity to respond to a variety of stimuli. Alternative splicing
appears to be an important mediator of neuronal differentiation,
diversity and plasticity. Recent studies of thunder mutant mice,
which contain a missense mutation in hnRNPLL and exhibit
defects in splicing, have revealed an important role for hnRNPLL
in survival of naı ¨ve and memory ab T cells [18]. Studies of thunder
mice revealed that hnRNPLL controls the accumulation and
longevity of circulating T cells, but the mechanism by which
hnRNPLL exerts these effects is not yet clear. CD28 is important
for promoting T cell survival, and our study links CD28
costimulation, hnRNPLL and T cell survival. Further studies of
thunder mice showed that hnRNPLL is necessary for appropriate
AS of CD45 [19], consistent with the study of Oberdoerffer et al
[14]. Thunder mice also have been utilized to identify hnRNPLL-
dependent splicing events by using exon microarrays to compare
exon usage in wild type and thunder mutant thymocytes and T cells
[18]. The striking overlap of exons showing hnRNPLL-dependent
alternative splicing in T cells and in the nervous system cells
suggests that hnRNPLL may serve a master regulator of
alternative splicing in a variety of cell types.
Biological processes tend to perturb groups of genes rather than
individual genes; therefore computational approaches have been
developed to identify the unusual overrepresentation of sets of
genes of interest that might point to underlying biological
mechanisms. This approach – termed ‘‘enrichment analysis’’ –
has been used to query expression profiling datasets for the
coordinate up-(or down-) regulation of a set of genes that share a
common biology [20,21]. For example, the activity of the
polycomb transcriptional complex during stem cell differentiation
was identified, in part, by analysis of microarray data that showed
Figure 5. Enrichment of hnRNPLL splicing targets in genes
alternatively spliced in T cells activated with TCR/CD28.
Representation of the overlap of hnRNPLL target gene transcripts from
Oberdoerffer et al. [14] with the genes displaying significant alternative
splicing in anti-CD3/CD28 versus anti-CD3 stimulation conditions.
Statistical significance of the overlap was calculated using the
hypergeometric distribution.
doi:10.1371/journal.pone.0040032.g005
Figure 6. CD28 costimulation upregulates hnRNPLL mRNA
expression in CD4 T cells. Sorted naı ¨ve CD4+CD25- T cells from wild
type C57BL/6 mice were stimulated with bead-bound anti-CD3 alone or
anti-CD3 plus anti-CD28 for the indicated times. Levels of mRNA were
measured by real-time PCR. The relative expression is shown as the
mean and SD of the fold induction above unstimulated T cells from
three independent experiments. *indicates ,0.05 in Student’s t test.
doi:10.1371/journal.pone.0040032.g006
Figure 7. CD28 costimulation promotes and sustains hnRNPLL
protein expression in CD4 T cells. Sorted naı ¨ve CD4+CD25- T cells
from wild type mice were stimulated with bead-bound anti-CD3 alone
or anti-CD3 plus anti-CD28 for the indicated times. (A, B) These results
are representative of at least 4 independent experiments.
doi:10.1371/journal.pone.0040032.g007
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during stem cell differentiation [22]. Analogous to gene-set
enrichment analysis, we developed a new method for identifying
splice factors active during T cell activation and differentiation by
integrating data from our exon arrays with information from an
entirely different source [14]. This novel analytical approach
identified a putative role for hnRNPLL in CD28-induced splicing.
Thus, our data suggest that genome-wide analysis of AS can be
used similarly to identify the ‘‘footprint’’ of alternatively spliced
genes resulting from the signaling of the T cell receptor, and due to
a specific splicing factor – in this case hnRNPLL. We anticipate
that it should be possible to assemble – either through laboratory
or analytic experiments – a compendium of sets of genes that are
subject to splicing by a library of specific splicing factors. Such a
compendium may prove a useful tool in the analysis of genome-
wide surveys of alternative splicing to identify the role of defined
splicing factors under specific biological conditions.
Further studies are needed to determine whether our finding
that more genes are alternately spliced than differentially
transcribed upon T cell activation is a general property of a single
cell type in different activation states, or rather, a specific feature of
T cells. Our findings may have broad applicability to the study of
derangements of T cell function. For example, aged T cells are
well-known to have different outcomes following activation,
including limited cytokine production and proliferative responses
[23,24]. Whether these effects can be attributed to age-dependent
changes in alternate splicing [25], as was recently shown to be the
case for neuronal calcium channels [26], dopamine channels [27],
and estrogen receptor alpha [28], is an exciting line of future
investigation. In addition, emerging data suggest that the
identification of disease-specific splice variants may provide novel
biomarkers and targets for therapy. Yet, little is known about the
factors that regulate alternative splicing. Our work has provided
insight into the regulation of expression of hnRNPLL, a key
orchestrator of splicing, in T cells and gives impetus to studies that
use bioinformatics and functional approaches to investigate the
impact of alternative splicing on T cell activation, differentiation,
and function.
Materials and Methods
Mice
C57BL/6 mice (The Jackson Laboratory) and OT-II
+/+
TCRa
2/2 mice (courtesy of Dr. Anjana Rao) were maintained
in a pathogen-free facility and used according to institutional and
National Institutes of Health guidelines. Harvard Medical School
is accredited by the American Association of Accreditation of
Laboratory Animal Care.
Ethics statement. The work was performed under a
protocol approved by the Harvard Standing Committee on
Animals in strict accordance with the recommendations in the
Guide for the care and use of Laboratory Animals of the National
Institutes of Health. The Harvard Medical School animal
management program is accredited by the Association for the
Assessment and Accreditation of Laboratory Animal Care,
International (AAALAC) (accreditation #000009), and meets
National Institutes of Health standards as set forth in the Guide for
the Care and Use of Laboratory Animals. The institution also
accepts as mandatory the PHS Policy on Humane Care and Use
of Laboratory Animals by Awardee Institutions and NIH
Principles for the Utilization and Care of Vertebrate Animals
Used in Testing, Research, and Training. There is on file with the
Office of Laboratory Animal Welfare (OLAW) an approved
Assurance of Compliance (A3431-01). Animals with euthanized
using C02 and every effort was made to minimize suffering.
T Cell Activation and RNA Preparation for Microarray
Analyses
M450 glycidyl ether beads (Dynal) were covalently coupled with
anti-CD3e (clone 2C11) plus either anti-CD28 (clone 37.51) or
hamster IgG isotype control (Ebioscience) as previously described
[29]. 10
7 beads were coated with 1 mg of anti-CD3e (20% of total
protein) plus either 4 mg of control hamster IgG (80% of total
protein) or 1.5 mg of anti-CD28 (30% of total protein) and 2.5 mg
of control hamster IgG (50% of total protein). CD4 T cells were
purified from spleens of OTII
+/+ TCRa
2/2 mice using CD4
microbeads and positive selection (Mitenyi Biotec), and plated (10
5
cells and 10
6 beads/well in 0.2 mL) in U-bottom tissue culture
wells for 24 hours in RPMI 1640 (Invitrogen) supplemented with
10% FBS, 2 mM L-glutamine, 10 mM HEPES, 1% penicillin/
streptomycin, and 50 mM 2-mercaptoethanol (R-10 media). RNA
was prepared from 10
7 T cells (RNEasy kit, Qiagen) and further
processed according to the manufacturer’s directions (Mouse Exon
Array 1.0, Affymetrix) at the Dana-Farber Cancer Institute
Microarray Core. Four independent replicates were performed
for each condition (naive, TCR-activated, and TCR/CD28
activated).
Exon Array Data Analysis
Analysis of mouse exon array data provides levels of expression
for 4,578,603 probes making up 1,198,032 probesets dispersed
among the exons of 269,283 transcripts. We corrected the
expression level of each probe, after eliminating cross-hybridizing
probes, using ProbeEffects software [13]. We then used selected
probes to calculate expression levels for each transcript using Jetta
software [13,30,31]. The expression level for each transcript was
calculated as the average expression level of all probes comprising
that transcript. For expression level, we used a cutoff of 2 fold
differences and empirical Bayesian testing, Limma software
package [12], to measure significance.
To calculate splicing, we followed the approach of Xing and
colleagues [32] to determine a splicing index for each probe, after
preprocessing to remove errant probes. The splicing index is the
ratio of each probe’s background-corrected probe intensity to the
average expression level of all probes for that transcript. Different
splicing indices between treatment conditions would indicate
differential splicing. We used the microarray analysis of differential
splicing (MADS) and microarray detection of alternative splicing
(MIDAS) software to calculate probability values of differential
splicing for each probeset [13]. For splicing differences to be
considered as significant, transcripts had to have statistically
significant different p values (p,0.01) in both statistical tests.
Over-representation of Gene Ontology biological processes was
analyzed using the NIH DAVID Functional Annotation web
server [33,34]. Significance values were corrected for multiple
testing [35].
We identified the list of 36 genes dependent on hnRNPLL for
alternative splicing from previously published data [14]. To
integrate this human dataset with our mouse dataset, we first
mapped the human genes to their mouse homologs using the JAX
lab informatics database [http://www.informatics.jax.org/], leav-
ing 33 unique mouse genes. We then calculated the overlap of
these hnRNPLL target genes with the genes displaying significant
alternative splicing in TCR/CD28 versus CD3 conditions.
Statistical significance of the overlap was calculated using the
hypergeometric distribution [36].
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Sorted naı ¨ve CD4+ CD25- T cells from C57BL/6 mice (.99%
pure) were activated with either anti-CD3 plus isotype or anti-
CD3 plus anti-CD28 mAb-coated beads in 96-well flat-bottom
tissue culture plates for the indicated time points in R-10 media.
Total cellular RNA was isolated by Trizol (Invitrogen), and 1 mg
RNA was used to reverse-transcribe mRNA into cDNA using
Reverse Transcription System (Promega), according to the
manufacturer’s protocol. The level of hnRNPLL mRNA was
determined by quantitative PCR using 5–10 ng cDNA in an ABI
7500 Fast System (Applied Biosystems). We normalized qPCR
data by b2- microglobulin using the DDCt method for relative
quantitation. TaqMan probes and primers were obtained from
Applied Biosystems. Statistical significance was determined using
the unpaired two-tailed t test.
Flow Cytometry
Sorted naı ¨ve CD4+CD25- cells from either OTII
+/+ TCRa
2/2
or C57BL/6 mice were activated with either anti-CD3 mAb plus
isotype or anti-CD3 plus anti-CD28 mAb-coated beads in 96-well
flat-bottom tissue culture plates for the indicated time points in R-
10 media. Cells were stained with mAbs to CD226 (Biolegend,
clone 10E5) or CCR9 (Biolegend, clone 9B1), and supernatants
used for analyses of IL-3 secretion by cytometric bead array (BD
Biosciences). The theoretical limit of IL-3 detection is 1.1 pg/ml
by this assay. Data were acquired on a LSR II (Beckton Dickinson)
and analyzed with FlowJo software.
Western Blot Analyses
Sorted naı ¨ve CD4+CD25- T cells from C57BL/6 mice were
activated with either anti-CD3 plus isotype or anti-CD3 plus anti-
CD28 mAb-coated beads in 96-well flat-bottom tissue culture
plates for the indicated time points in R-10 media. Whole cell
lysates were prepared in ice-cold lysis buffer containing 1% Triton
X-100, 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 2 mM EDTA,
protease inhibitor cocktail (Roche), and phosphatase inhibitor
cocktail (Pierce). Protein concentration was measured by the BCA
method (Pierce). Twenty mg of whole cell lysates were boiled in
sample buffer, separated on 10% SDS-PAGE and analyzed by
Western blotting using a hnRNPLL-specific polyclonal Ab
(Abcam). The membrane was stripped and reprobed with actin
Ab (Sigma). HRP-conjugated anti-rabbit or anti-mouse secondary
Ab (GE Health) was used, and ECL (GE Health) was used for
detection of bound antibody.
Supporting Information
Figure S1 Transcript-level expression for the genes
most upregulated or downregulated upon activation of
T cells. Expression is shown on a log2 scale on the vertical axis.
Colors are given for convenience of interpretation: naı ¨ve (red),
TCR-activated (green) and TCR/CD28-activated (blue). Repli-
cates shown for each transcript are fully independent across mice,
days, and microarray batches. (A) Transcripts showing most
differential expression comparing naı ¨ve and TCR-activated T
cells. (B) Transcripts showing most differential expression
comparing naı ¨ve and TCR/CD28-activated T cells. (C) Tran-
scripts showing most differential expression comparing TCR-
activated and TCR/CD28-activated T cells.
(TIF)
Figure S2 Volcano plots showing differential expression
between naı ¨ve T cells, TCR-activated T cells, and TCR/
CD28-activated T cells.
(TIF)
Figure S3 Network visualization of functionally-related
groups of genes affected by CD28-induced alternate
splicing. Relationships between of functionally-related groups of
genes identified by enrichment analysis in TCR/CD28-activated
T cells compared to TCR-activated T cells were visualized using
GeneMANIA. (A) DNA metabolic process (B) RNA processing (C)
RNA splicing.
(TIF)
Table S1 Transcripts expressed only in naı ¨ve T cells, TCR-
activated, or TCR/CD28 Activated T cells.
(DOC)
Table S2 Biological processes enriched in transcripts expressed
only in Naı ¨ve T cells or TCR/CD28 activated T cells.
(DOC)
Table S3 All genes with greater than 1.4 fold changes in
transcript-level expression in TCR-activated compared to naı ¨ve T
cells and TCR/CD28 activated compared to naı ¨ve T cells or
TCR/CD28 activated compared to TCR-activated T cells.
(DOC)
Table S4 Unique transcripts spliced only in naı ¨ve T cells, TCR-
activated T cells, or TCR/CD28 T cells.
(DOC)
Table S5 Unique Biological processes in transcripts differentially
expressed or spliced between naı ¨ve T cells and TCR activated T
cells, naı ¨ve T cells and TCR/CD28-activated T cells.
(DOC)
Table S6 Biological processes of the 1,047 transcripts differen-
tially spliced between TCR-activated and TCR/CD28-activated
T cells.
(DOC)
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